Healthcare facilities are increasingly adopting healthcare predictive analytics, mainly in areas such as clinical trials, administration, and operations management, in order to provide the best care possible.

The carbon footprint management market is expected to expand significantly in the forecast period from 2022 to 2026.

The active pharmaceutical ingredients (API) manufacturing market is poised to achieve significant growth amid rapid technological advancements in the next few years, according to expert forecasts published in a new report by The Business Research Company.

The increase in development of biologics (drugs made from living organisms) is driving the adoption of biosimilars, which is a cheaper alternative with the same efficacy when compared to biologics.

The fast-growing global wearable electrocardiogram (ECG) devices market offers exciting growth opportunities for competitors.

A new report from The Business Research Company (TBRC) provides expert data on global food and beverage market growth, drivers, and trends.

The Business Research Company’s dental services market report highlights the largest region that is shaping this industry — North America.

The global biologics market is expected to see a 12% growth rate and reach $420.55 billion by 2025, according to a new report by The Business Research Company.

Worldwide, we are seeing advances in internet penetration and the countless results from it. These are directly affecting the alternative data industry, causing huge growth opportunities in the market.

Because the pegfilgrastim biosimilars market is highly concentrated with only a few large players, gaining an in-depth understanding of the top competitors and their key strategies is crucial. A new report by The Business Research Company provides detailed information on the pegfilgrastim biosimilars competitive landscape. Read on to learn key insights from the report.